
|Articles|November 27, 2007
NIH to meet over use of hydroxyurea for sickle cell disease
NIH to meet over use of hydroxyurea for sickle cell disease
Advertisement
How effective is the use of hydroxyurea to treat sickle cell anemia? The National Institutes of Health will be holding a consensus conference to address this issue. Sickle cell disease is an inherited blood disorder that affects up to 75,000 people in the United States, many of whom are from sub-Saharan Africa and other areas. The
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacies Adapting to IRA-Negotiated Drug Prices Despite Looming Financial Concerns
2
More Than 200 Organizations Denounce Childhood Vaccine Schedule Change
3
Adjunctive Lumateperone Maintains Remission Rates for Major Depressive Disorder
4
Trump Administration Lays Out Great Healthcare Plan for Lower Patient Costs
5










































































































































































































